Reirradiation of gliomas with hypofractionated stereotactic radiotherapy: efficacy and tolerance analysis at a single center
Re-irradiation using HFSRT for recurrent high-grade gliomas is viable and well-tolerated, demonstrating survival rates comparable to existing literature. These findings underscore the potential of HFSRT in managing recurrent high-grade gliomas.
Authors
- J. Valero (ORCID: https://orcid.org/0000-0002-3506-5088)
- E. Sánchez Saugar
- P. Fernández-Letón
- L. Alonso Iracheta
- Beatriz Álvarez (ORCID: https://orcid.org/0000-0003-2244-801X)
- M. García-Aranda
- R. Ciérvide (ORCID: https://orcid.org/0000-0003-0130-878X)
- D. Zucca
- Carmen Rubio (ORCID: https://orcid.org/0000-0002-4343-7814)
- Á. Montero (ORCID: https://orcid.org/0000-0001-5566-0493)
- Xin Chen (ORCID: https://orcid.org/0000-0002-1920-8835)
- Rosa Alonso
- Mercedes López González (ORCID: https://orcid.org/0000-0003-0490-6857)
- O. Hernando Requejo
Institutions
- HM Hospitales (ES)
Publication Details
- Journal
- Reports of Practical Oncology & Radiotherapy
- Published
- 2024-12-04
- DOI
- https://doi.org/10.5603/rpor.102820
- Citations
- 2
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.88